PFIZER INC. for PFIZER INC.
What was lobbied
8 issue areas, each in the filer's own words, with who lobbied on it and where.
Defense DEF
VA Drug Coverage Smoking Cessation Coverage
| Lobbyist | Covered position, as disclosed |
|---|---|
| LOUIS A LAMARCA | — |
Trade (domestic/foreign) TRD
US- China Trade Dialogues (JCCT) - market access and IP issues Trans Pacific Partnership talks US - EU Dialogues (TEC) - market access and regulatory issues Japan Market Access and Regulatory Issues US-Korea Free Trade Agreement (no bills) US-Peru Free Trade Agreement (no bills) US-Columbia Free Trade Agreement (no bills) US-Panama Free Trade Agreement (no bills) Poland market access (no bills) Russia market access (no bills) Turkey Market Access (no bills) Israel Patent Issues (no bills) Taiwan - Market Access Issues (TIFA talks) APEC Life Sciences Innovation Forum Mexico IP and market access issues Brazil IP Thailand Compulsory Licensing India IP and market access issues Australian FTA Implementation Special 301 Reform Legislation Trade Enforcement Legislation
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOSEPH DAMOND | — |
| ANTHONY PRINCIPI | — |
Taxation/Internal Revenue Code TAX
Deferral Deferral for active-financing income- extension S. 1203 - R& E Tax Credit Extension and Enhancement H.R. 422 - R&E Tax Credit Extension and Enhancement H.R. 2098 - CFC Look Through Extension
| Lobbyist | Covered position, as disclosed |
|---|---|
| KIMBERLY JANE PINTER | — |
| ANTHONY PRINCIPI | — |
Copyright/Patent/Trademark CPT
S. 515 - Patent Reform Act of 2009 S. 299 - Expert Patent Courts Pilot Program Act, 1/09 S. 369 - Preserve Access to Affordable Generics, 2/09 H.R. 1260 - Patent Reform Act, 3/09 H.R. 1706 - Protecting Consumer Access to Generics Drug Act, 3/09 H.R. 1548 - Pathway for Biosimilars Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN PAUL HALLIWELL | — |
| LOUIS A LAMARCA | — |
| ANTHONY PRINCIPI | — |
Medicare/Medicaid MMM
Medicare Prescription Drug Benefit Implementation Medicaid Rebates Medicare Coverage Average Manufacturer Price Regulation H.R. 2502 - Comparative Effectiveness Research Act H.R. 3200 - America's Affordable Heath Choices Act of 2009. H.R. 3675 - National Quality Cancer care Demonstration Project Act of 2009 H.R. 684 - The Medicare Prescription Drug Savings and Choice Act of 2009
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRISTOPHER CAREY | — |
| JOHN PAUL HALLIWELL | — |
| ANTHONY PRINCIPI | — |
Budget/Appropriations BUD
Administration budget proposal, deferral and other international tax issues H.R.3293 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2010
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRONWEN KAYE | — |
| KIMBERLY JANE PINTER | — |
| ANTHONY PRINCIPI | — |
Consumer Issues/Safety/Products CSP
S.80 - Pharmaceutical Market Access Act, 1/09 S. 501 - Fair prescription Drug Competition Act, 3/09 S. 882 - Drug and Device Accountability Act H.R. 573 - act to prohibit the marketing of authorized generic drugs, 1/09 H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicines Act, 3/09 H.R. 1548 - Pathway for Biosimilars Act, 3/09 H.R. 759 - The Food, drug and Cosmetic Globalization Act, 1/09 H.R. 1259 - Dextromethorphan Distribution Act 4/09 S. 1383 - Dextromethorphan Abuse Reduction Act 6/09
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN PAUL HALLIWELL | — |
| LOUIS A LAMARCA | — |
| ANTHONY PRINCIPI | — |
| ANGELA WALKER RIEMER New | — |
Health Issues HCR
Veterans Healthcare issues Health Reform Comparative Effectiveness Research Health Information Technology Follow on Biologics Medicare Part D S. 4 - Comprehensive Health Reform Act (1/09) S. 45 - Health Liability Reduction Act (1/09) S. 301 - Physician Payments Sunshine Act (1/09) S. 501 - Fair Prescription Drug Competition Act (3/09) S. Con Res 13 - Budget Reconciliation H.R. 15 - National Health Insurance Act (1/09) H.R. 1 - The American Recovery and Reinvestment Act H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicine Act H.R. 2 - Children's Health Insurance Program Reauthorization Act of 2009 H.R. 1548 - Pathway for Biosimilars Act H.R. 1549 The Preservation of Antibiotics for Medical Treatment Act H.R. 2400 - Strategies to Address Antimicrobial Resistance Act H.R. 3200 - America's Affordable Health Choice Act H.R. 3962 - Affordable Healthcare for America Act H.R. 3590 - Patient Protection and Affordable Care Act H.R. 4489 - FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act H. Con Res 85 - Budget Resolution 2010
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRISTOPHER CAREY | — |
| MARIA CINO | — |
| JOHN PAUL HALLIWELL | — |
| BRONWEN KAYE | — |
| LOUIS A LAMARCA | — |
| ANTHONY PRINCIPI | — |
| ANGELA WALKER RIEMER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.